carteolol has been researched along with Brain Vascular Disorders in 1 studies
Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasui, K | 1 |
| Ohmoto, T | 1 |
| Tamaki, T | 1 |
| Fukui, K | 1 |
| Iwao, H | 1 |
| Abe, Y | 1 |
1 other study available for carteolol and Brain Vascular Disorders
| Article | Year |
|---|---|
Effects of prolonged treatment with beta-adrenoceptor antagonist, carteolol on systemic and regional hemodynamics in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Body Weight; Cardiac Output; Carteolol; Cerebrovascular Disorders; Hemodyna | 1991 |